The Gluten Study

Celiac Disease is a chronic inflammatory intestinal disorder that causes the immune system to attack the small intestine when the patient consumes gluten (found in wheat, rye, etc). In this Phase 1 clinical trial, the study drug will be administered to healthy volunteers with no history of Celiac Disease.

The study drug is administered via injection and has the potential to impact the development of Celiac Disease. At this time there are no approved treatments for Celiac Disease. The only option patients currently have is to follow a strict gluten-free diet. Approximately 1 in 100 Australians are affected by Celiac Disease, and so there is a large demand for new treatment options.

This clinical trial has been approved by an independent ethics committee, and you will be reimbursed for your time.

Call us on 1800 243 733 to discuss your eligibility today!